Published in Drug Des Devel Ther on December 17, 2014
The role of microRNAs in intrahepatic cholangiocarcinoma. J Cell Mol Med (2016) 0.78
Prognostic Factors of Cholangiocarcinoma After Surgical Resection: A Retrospective Study of 293 Patients. Med Sci Monit (2015) 0.77
Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol (2012) 3.56
Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg (1990) 3.25
Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg (2001) 2.57
Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg (2011) 2.42
Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study. Lancet Oncol (2010) 2.36
Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg (2005) 2.23
Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys (2000) 2.21
Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol (2011) 2.13
Pathological aspects of cholangiocarcinoma. J Pathol (1983) 1.87
Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation (2000) 1.79
Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg (2002) 1.75
Cholangiocarcinoma in north-east Thailand. Lancet (1990) 1.34
Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg (2005) 1.32
Resection of intrahepatic cholangiocarcinoma: a Western experience. J Hepatobiliary Pancreat Surg (1999) 1.31
Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery (2000) 1.25
Is liver transplantation indicated for cholangiocarcinoma? Am J Surg (1993) 1.20
Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma. Cancer (1989) 1.19
Intrahepatic cholangiocarcinoma. World J Surg (1997) 1.11
Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. Ann Surg Oncol (2004) 1.09
Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol (2008) 1.07
Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg (2001) 1.06
Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg (2000) 1.06
Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? J Surg Oncol (1998) 1.04
Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients. Ann Surg Oncol (2008) 1.03
Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma. Ann Oncol (1999) 1.00
Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma. World J Surg (2001) 0.99
A western surgical experience of peripheral cholangiocarcinoma. Br J Surg (1996) 0.99
Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases. J Surg Oncol (2007) 0.94
The role of chemotherapy in biliary tract carcinoma. HPB (Oxford) (2008) 0.93
Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma. World J Surg (2008) 0.90
Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index. Ann Surg Oncol (2010) 0.89
Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma. World J Surg (2005) 0.87
Intrahepatic cholangiocarcinoma in Taiwan. J Hepatobiliary Pancreat Surg (1999) 0.86
Mitomycin C with weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract and periampullar carcinomas. Anticancer Drugs (2001) 0.86
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract. Br J Cancer (2004) 0.85
Is liver transplantation indicated for cholangiocarcinoma? J Hepatobiliary Pancreat Surg (1998) 0.85
Weekly 24 h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas. Anticancer Drugs (1998) 0.82
The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients. Anticancer Res (2008) 0.81
Diagnosis and treatment of cholangiocellular carcinoma of the liver. Hepatogastroenterology (1990) 0.81
A phase II trial of tegafur-uracil plus leucovorin (LV) in the treatment of advanced biliary tract carcinomas. Jpn J Clin Oncol (2003) 0.79
A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma. Cancer Chemother Pharmacol (2009) 0.76